2019 Conference

CONTAMINATION: WHERE DO WE STAND?

 
Carcinogens in hospitals: identification, construction of limit values and prevention of exposures
M El Yamani,
Département santé environnement travail, Santé Publique France

Exposure of healthcare workers to cytotoxic drugs
S. N’Daw, D. Flavien, M. Philippe, H. Ogier, R. Alain
Institut National de Recherche et de Sécurité (INRS), Département Polluants et santé, rue du Morvan, CS 60027, 54519 VANDOEUVRE LES NANCY Cedex, France.
1. Pharmacie à Usage Intérieur, département conception, fabrication et contrôle du médicament, CHU Amiens- Picardie, Amiens, France.
2. Laboratoire AGIR EA 4294, Université de Picardie Jules Verne, Amiens, France

 

ROUND TABLE

 
Best preparation practices: international convergence and divergence
S. Crauste-Manciet, University Hospital Bordeaux, France
V. Salomon, Agence Nationale de Sécurité du Médicament et des produits de santé, France
F. Sadeghipour, CHUV Lausanne, Switzerland
J-F. Bussières, University Hospital Montréal, Canada
A. Beaney, North Tees and Hartlepool NHS Foundation Trust, UK
P. Le Brun, Leiden University Medical Center, The Netherlands
P. Kienle, Cardinal Health Pennsylvanie, USA

 

Microbiological stability consensus Working group
Working group:
Prof. Sylvie Crauste-Manciet, France - Prof. Irene Krämer, Germany - Prof. Frederic Lagarce, France - Prof. Valerie Sautou, France - Dr Alison Beaney, UK - Dr Julian Smith, UK - Mr V’Iain Fenton-May, UK - Prof. Jean-Daniel Hecq, Belgium - Prof. Farshid Sadeghipour, Switzerland - Dr Paul Le Brun, The Netherlands

 

HOT TOPICS

 
Formulation and stability study of low-dose midazolam capsules for clinical trial
P.N. Boivin1, A.C. Bonnaure1, M.A. Lester1
1 Pharmacy department, Rennes University Hospital, Rennes, France

 
Stability of frozen 1% voriconazole eye-drops in both glass and innovative containers
Marine Roche1,2, MSc, PharmD ; Damien Lannoy1,2, Ph.D., PharmD ; Florence Bourdon1, Ph.D., PharmD ; Cécile Danel2, Ph.D. ; Pierre Labalette3, Ph.D., MD ; Christophe Berneron1, PharmD ; Nicolas Simon1,2, Ph.D. PharmD ; Pascal Odou1,2, Ph.D., PharmD.
1 CHU Lille, Institut de Pharmacie, F-59000 Lille, France
2 Univ. Lille, EA 7365—GRITA—Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France

 
Rapid microbiological sterility test for cytotoxic batch control: is drug complexation effective for restoring microbiological growth?
Sangnier Maïté1, Bouguéon Guillaume1,2, Dubois Véronique3,4, Crauste-Manciet Sylvie1,2
(1) Pharmaceutical Technology Department, Bordeaux university hospital (CHU de Bordeaux), France
(2) ARNA Laboratory-ChemBioPharm U1212 INSERM - UMR5320, CNRS - University of Bordeaux, France
(3) Fundamental Microbiology and Pathogenicity Laboratory UMR-CNRS 5234 – University of Bordeaux, France
(4) Microbiology department, Bordeaux university hospital (CHU de Bordeaux), France

 
Fecal microbiota transplantation: from the raw material to the pharmaceutical preparation
R.BATISTA, Service de pharmacie, Hôpitaux Universitaires Paris Centre, Assistance Publique – Hôpitaux de Paris

 
Theranostics and radiopharmacy: a technical example of neuroendocrine tumour management (Gallium-68 ; Lutetium 177)
F. Debordeaux,
Nuclear medicine department, University Hospital Bordeaux

 
Man to Mars with an artificial ecosystem
C. Lasseur, European Space Agency & Partenaires MELiSSA

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

GERPAC
Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data